As of August 28, 2026, Kazia Therapeutics Limited (KZIA) has a DilutionWatch DilutionScore of 67/100, rated HIGH dilution risk. This is a component-limited score because one or more material inputs are unavailable or not applicable. Kazia Therapeutics Limited has a market capitalization of $146.04M, 809.42M shares outstanding.
This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.
Score Breakdown
📊Float Risk—
Dilution Forecast
☀️
Clear
No significant dilution signals
model est. 5%
📉 Score Deterioration
model 10%
• Score in HIGH risk zone (67/100)
Market Data
Market Cap$146.04M
Shares Outstanding809.42M
FloatN/A
Cash$49.91M
Debt$71.0K
Short InterestN/A
Institutional Holdings
30.8% institutional ownership
Source: Yahoo Finance · Detailed 13F holder data available for tracked tickers
Short Interest
Short Interest679.0K
Days to Cover3.4
% of FloatN/A
FINRA data as of Jul 31, 2026
Recent SEC Activity
No recent SEC insights
Recent News
No recent news
Track KZIA Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking KZIA — Free
Real-time SEC alerts
DilutionScore™ tracking
No credit card required
Score Coverage Note
- Float Risk is excluded because public-float data is unavailable.